Fortune Mate Indonesia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Fortune Mate Indonesia Tbk trades at Rp256 (market cap 1.61T, 26.6K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 3.4× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 26.6K). Which is the better fit depends on your goals.
| FMII | PRDL | |
|---|---|---|
Market Cap | 1.61T | 470.58B |
Volume | 26.6K | 18.86M |
Lot | 266 | 188.57K |
Turnover | 6.74M | 4.97B |
Average Price | 253.51 | 263.63 |
Value | 6.74M | 4.97B |
Indicative Equilibrium Price | 256 | 264 |
Indicative Equilibrium Volume | 1 | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →